Free Trial

INVO Bioscience Q2 2024 Earnings Report

INVO Bioscience logo
$2.00 0.00 (0.00%)
As of 03/31/2025

INVO Bioscience EPS Results

Actual EPS
-$0.62
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Bioscience Revenue Results

Actual Revenue
$1.84 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Bioscience Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

INVO Bioscience Earnings Headlines

NAYA Biosciences Inc trading halted, news pending
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
NAYA Biosciences to effect 1-for-12 reverse split
NAYA Biosciences supports executive order on fertility treatment access
NAYA Biosciences To Raise $9.5 Mln Through Public Offering Of Units
See More INVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Bioscience and other key companies, straight to your email.

About INVO Bioscience

INVO Bioscience (NASDAQ:INVO), together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Bioscience Profile

More Earnings Resources from MarketBeat